These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 3534803)
1. Review of the Multicenter Trial Committee report: a prospective, randomized study on the prophylaxis of postoperative deep venous thrombosis. Comerota AJ Pharmacotherapy; 1986; 6(4 Pt 2):18S-22S. PubMed ID: 3534803 [TBL] [Abstract][Full Text] [Related]
2. Prophylactic efficacy of low-dose dihydroergotamine and heparin in postoperative deep venous thrombosis following intra-abdominal operations. J Vasc Surg; 1984 Sep; 1(5):608-16. PubMed ID: 6389909 [TBL] [Abstract][Full Text] [Related]
3. The use of dihydroergotamine and heparin in the prophylaxis of deep venous thrombosis. Comerota AJ; White JV Chest; 1986 May; 89(5 Suppl):389S-395S. PubMed ID: 3698718 [TBL] [Abstract][Full Text] [Related]
4. Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis. Sasahara AA; Koppenhagen K; Häring R; Welzel D; Wolf H Br J Surg; 1986 Sep; 73(9):697-700. PubMed ID: 3530367 [TBL] [Abstract][Full Text] [Related]
5. United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis. DiSerio FJ; Sasahara AA Am J Surg; 1985 Oct; 150(4A):25-32. PubMed ID: 3901790 [TBL] [Abstract][Full Text] [Related]
6. Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis. A multicenter trial. The Multicenter Trial Committee. JAMA; 1984 Jun; 251(22):2960-6. PubMed ID: 6371278 [TBL] [Abstract][Full Text] [Related]
7. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569 [TBL] [Abstract][Full Text] [Related]
8. Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis. Kakkar VV; Stringer MD; Hedges AR; Parker CJ; Welzel D; Ward VP; Sanderson RM; Cooper D; Kakkar S Am J Surg; 1989 Apr; 157(4):413-8. PubMed ID: 2539025 [TBL] [Abstract][Full Text] [Related]
9. [Optimation of postoperative prophylaxis of thrombosis in gynaecology (author's transl)]. Adolf J; Buttermann G; Weidenbach A; Gmeineder F Geburtshilfe Frauenheilkd; 1978 Feb; 38(2):98-104. PubMed ID: 631536 [TBL] [Abstract][Full Text] [Related]
10. Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen. Voth D; Schwarz M; Hahn K; Dei-Anang K; al Butmeh S; Wolf H Neurosurg Rev; 1992; 15(4):289-94. PubMed ID: 1336131 [TBL] [Abstract][Full Text] [Related]
11. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial. Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673 [TBL] [Abstract][Full Text] [Related]
12. Prevention of postoperative deep vein thrombosis by one daily injection of low molecular weight heparin and dihydroergotamine. Baumgartner A; Jacot N; Moser G; Krähenbühl B Vasa; 1989; 18(2):152-6. PubMed ID: 2545054 [TBL] [Abstract][Full Text] [Related]
13. Prevention of postoperative deep vein thrombosis by a combination of subcutaneous heparin with subcutaneous dihydroergotamine or oral sulphinpyrazone. Veth G; Meuwissen OJ; van Houwelingen HC; Sixma JJ Thromb Haemost; 1985 Oct; 54(3):570-3. PubMed ID: 4089792 [TBL] [Abstract][Full Text] [Related]
14. Prophylaxis for postoperative deep-vein thrombosis. Synergistic effect of heparin and dihydroergotamine. Kakkar VV; Stamatakis JD; Bentley PG; Lawrence D; de Haas HA; Ward VP JAMA; 1979 Jan; 241(1):39-42. PubMed ID: 758493 [TBL] [Abstract][Full Text] [Related]
15. A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery. Steiner RA; Keller K; Lüscher T; Schreiner WE Arch Gynecol Obstet; 1989; 244(3):141-50. PubMed ID: 2544152 [TBL] [Abstract][Full Text] [Related]
16. Combined dihydroergotamine and heparin prophylaxis of postoperative deep vein thrombosis: proposed mechanism of action. Comerota AJ; Stewart GJ; White JV Am J Surg; 1985 Oct; 150(4A):39-44. PubMed ID: 3901791 [TBL] [Abstract][Full Text] [Related]
17. Prophylaxis of deep vein thrombosis after major abdominal surgery. Comparison between dihydroergotamine-heparin and intermittent pneumatic calf compression and evaluation of added graduated static compression. Mellbring G; Palmér K Acta Chir Scand; 1986 Oct; 152():597-600. PubMed ID: 3544626 [TBL] [Abstract][Full Text] [Related]
18. Prevention of postoperative thromboembolism by various treatments. Controlled clinical trial in 632 patients using 125I-fibrinogen uptake test and lung perfusion scans in patients with deep venous thrombosis. Hör G; Buttermann G; Theisinger W; Pabst HW Eur J Nucl Med; 1976 Dec; 1(4):197-203. PubMed ID: 801352 [TBL] [Abstract][Full Text] [Related]
19. Operative venodilation: a previously unsuspected factor in the cause of postoperative deep vein thrombosis. Comerota AJ; Stewart GJ; Alburger PD; Smalley K; White JV Surgery; 1989 Aug; 106(2):301-8: discussion 308-9. PubMed ID: 2763031 [TBL] [Abstract][Full Text] [Related]
20. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. J Bone Joint Surg Am; 1989 Feb; 71(2):311-2. PubMed ID: 2918019 [No Abstract] [Full Text] [Related] [Next] [New Search]